Russell Barrans, Chief Commercial Officer at Evofem Biosciences, Inc. (EVFM), bought 279 shares at $3.55 ($990) on 2018-11-21, disclosed to the SEC on 2018-11-26.
Open-market purchase of $990 EVFM by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| EVFM | SELL | 2020-02-21 | $194K | — | Filing → |
| EVFM | SELL | 2020-01-21 | $10K | — | Filing → |
| EVFM | BUY | 2018-08-13 | $7K | — | Filing → |